# ASBV

> ASBV is a VC fund in Shenzhen backing Health Care and Medical. See 28 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shenzhen, China
- Total investments: 28
- Last investment: Sep 2023
- Lead investor: 46%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/%E6%BE%B3%E9%93%B6%E8%B5%84%E6%9C%AC
- Website: http://www.asbvchina.com

ASBV is a VC fund in Shenzhen focused on Health Care and Medical. ASBV focuses on early and mid-term venture capital investments.

## Contacts

5 contacts available for ASBV. Shizune tracks 7 team members at ASBV. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/asbv?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3M–$14M |
| Angel | $425k–$425k |
| Series A | $1.4M–$34M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 11 | 39% |
| Medical | 9 | 32% |
| Biotechnology | 6 | 21% |
| Manufacturing | 6 | 21% |
| Medical Device | 4 | 14% |

40 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 11 | 39% |
| Series A | 10 | 36% |
| Angel | 4 | 14% |
| Series B | 2 | 7% |
| Funding Round | 1 | 4% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 24 | 86% |
| Australia | 1 | 4% |
| Hong Kong | 1 | 4% |
| United States | 1 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Gang Xiong | Founding Partner, Chairman | 1 | https://shizune.co/investors/profile/gang-xiong |
| Guangyao Ou | Partner, CEO | 0 | https://shizune.co/investors/profile/guangyao-ou |
| Jin Li | Partner, Chief Investment Officer | 0 | https://shizune.co/investors/profile/jin-li-e067 |
| Jiping Sun | Founding Partner, Director | 0 | https://shizune.co/investors/profile/jiping-sun |
| Yan Hu | Chief Operating Officer | 0 | https://shizune.co/investors/profile/yan-hu |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Longyue Mechanical and Electrical Technology | Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services. | $13.7M | Seed | Sep 11, 2023 |  |
| Kaiyue Life | Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours. |  | Seed | Jun 12, 2023 |  |
| Boundary Intelligent Control | Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities. |  | Seed | May 22, 2023 |  |
| Bosheng Medical | Bosheng Medical is a system provider in the field of minimally invasive surgical endoscope camera. |  | Series A | Sep 09, 2022 |  |
| Dameng Bio | Dameng Bio is a medical firm specializing in the R&D, production, and service of tumor pathological diagnostic instruments and reagents. |  | Series A | Dec 17, 2021 |  |
| Huasaiboman Medical Cell Biology | Warseeberman is a cell therapy solution provider, focusing on new cell therapy technologies, based on clinical research, and dedicated to the development of immune cell drug products for the treatment of solid tumors and stem cell therapy products for the treatment of degenerative diseases. The company aims at the cutting-edge technology of tumorimmunotherapy, focuses on the development of tumor infiltrating lymphocyte (TIL) drugs for solid tumors, and cooperates with many hospitals to establish a solid tumor and clinical transformation research institute, dedicated to bringing life to solid tumor patients Hope. |  | Seed | Nov 23, 2021 |  |
| Zonsen Peplib Biotech | Zonsen aims to build up a super-sized peptide compound library and provide peptide drug discovery and development services. | $34M | Series A | Apr 30, 2021 |  |
| ZSPepLib | ZSPepLib is a peptide lead drug developer, established in January 2017, coordinates Zhuzhou, Hunan. It is a platform-based company specializing in peptide lead drug discovery, focusing on the development, production, sales and new peptide drugs of the large-capacity peptide library. Screening R&D technical services. | $34M | Series A | Apr 28, 2021 |  |
| Longyue Mechanical and Electrical Technology | Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services. |  | Angel | Jan 01, 2021 |  |
| NeuroEchos | Nuoer Medical was established in August 2017, focusing on the field of functional neurosurgery, with precise EEG as the entry point, providing integrated diagnosis and treatment solutions for various diseases caused by abnormal discharge of the nervous system. | $4.3M | Seed | Dec 30, 2020 |  |

10 of 28 investments shown.

## Co-investors
- [CAS Investment Management](https://shizune.co/investors/profile/cas-investment-management) — VC Fund, 2 deals together
- [Cowin Capital](https://shizune.co/investors/profile/cowin-capital) — VC Fund, 2 deals together
- [Fortune Venture Capital](https://shizune.co/investors/profile/fortune-venture-capital) — VC Fund, 2 deals together
- [Legend Star](https://shizune.co/investors/profile/legendstar) — VC Fund, 2 deals together
- [BIOCHING CAPITAL](https://shizune.co/investors/profile/bioching-capital) — VC Fund, 1 deal together
- [CDH Investments](https://shizune.co/investors/profile/cdh-investments) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alibaba Entrepreneurs Fund](https://shizune.co/investors/profile/alibaba-entrepreneurs-fund) — VC Fund
- [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund
- [Gobi Partners](https://shizune.co/investors/profile/gobi-partners) — VC Fund

## Featured in investor lists
- [Health Care Investors in Asia](https://shizune.co/investors/health-care-investors-asia)
- [Health Care Investors in China](https://shizune.co/investors/health-care-investors-china)
- [Health Care VC Funds in China](https://shizune.co/investors/health-care-vc-funds-china)
- [Medical Investors in Asia](https://shizune.co/investors/medical-investors-asia)
- [Medical VC Funds in Asia](https://shizune.co/investors/medical-vc-funds-asia)
- [Medical Device VC Funds in China](https://shizune.co/investors/medical-device-vc-funds-china)

## FAQ

### What does ASBV invest in?

ASBV invests primarily in Health Care, Medical and Biotechnology startups, most often at Seed and Series A stage. Most of the 28 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is ASBV's check size?

ASBV typically joins rounds of $3M–$14M at Seed, $425k–$425k at Angel and $1.4M–$34M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds ASBV participates in.

### How do I contact ASBV?

Public channels for ASBV include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at ASBV?

The team at ASBV includes Gang Xiong (Founding Partner, Chairman), Guangyao Ou (Partner, CEO) and Jin Li (Partner, Chief Investment Officer), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co